Atjaunin\u0101tais kompens\u0113jamo z\u0101\u013cu cenr\u0101dis Lietuv\u0101 st\u0101j\u0101s sp\u0113k\u0101 j\u016blij\u0101, un tas izpeln\u012bj\u0101s neviennoz\u012bm\u012bgu rezonansi.<\/p>\n
Vesel\u012bbas ministrijas skat\u012bjums<\/strong><\/p>\n K\u0101 nor\u0101da Lietuvas Vesel\u012bbas ministrija, jaunais kompens\u0113jamo z\u0101\u013cu izv\u0113les meh\u0101nisms tika ieviests pag\u0101ju\u0161aj\u0101 gad\u0101, lai racionaliz\u0113tu oblig\u0101t\u0101s vesel\u012bbas apdro\u0161in\u0101\u0161anas fonda l\u012bdzek\u013cu izmanto\u0161anu un papla\u0161in\u0101tu kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu un pacientu skaitu, kas tos sa\u0146em. \u0160is meh\u0101nisms nosaka maksim\u0101lus \u201cgriestus\u201d pacientu piemaks\u0101m, pamatojoties uz piec\u0101m zem\u0101kaj\u0101m z\u0101\u013cu cen\u0101m ES.<\/p>\n Farmaceitisko produktu ra\u017eot\u0101ju asoci\u0101cijas ba\u017eas<\/strong><\/p>\n Tom\u0113r atjaunin\u0101tais saraksts rada ba\u017eas Farmaceitisko produktu ra\u017eot\u0101ju asoci\u0101cij\u0101. Vi\u0146i nor\u0101da: \u201cLietuv\u0101 jaunaj\u0101 kompens\u0113jamo z\u0101\u013cu sarakst\u0101 ir iek\u013cauts maz\u0101k z\u0101\u013cu. Tas ir saist\u012bts ar to, ka Lietuva nav piel\u0101gojusi savu cenu re\u017e\u012bmu, padarot m\u016bsu valsti nepievilc\u012bgu ra\u017eot\u0101jiem. Pacienti s\u016bdzas, ka vi\u0146iem ir j\u0101p\u0113rk nepiecie\u0161am\u0101s z\u0101les bez kompens\u0101cijas.\u201d<\/p>\n Farmaceitisko produktu ra\u017eot\u0101ju asoci\u0101cijas valdes priek\u0161s\u0113d\u0113t\u0101ja Laisvida Kru\u0161iene uzsver, ka probl\u0113mas rada pras\u012bba nepaaugstin\u0101t kompens\u0113jamo z\u0101\u013cu cenu. Pa\u0161laik kompens\u0113jamo z\u0101\u013cu cena Lietuv\u0101 tiek noteikta, pamatojoties uz akt\u012bv\u0101s vielas vid\u0113jo cenu, kas apr\u0113\u0137in\u0101ta, \u0146emot v\u0113r\u0101 zem\u0101k\u0101s cenas piec\u0101s Eiropas Savien\u012bbas valst\u012bs. Asoci\u0101cija uzskata, ka \u0161\u012b proced\u016bra nepiesaista ra\u017eot\u0101jus.<\/p>\n Norameda skat\u012bjums<\/strong><\/p>\n Norameda \u0123ener\u0101ldirektors Audrius Leiva nor\u0101da, ka sist\u0113ma, kas nosaka \u0123en\u0113risko z\u0101\u013cu cenas, pamatojoties uz citiem ES tirgiem, darbojas jau k\u0101du laiku, un \u0161is gads nav iz\u0146\u0113mums. Tom\u0113r vi\u0146\u0161 atz\u012bst, ka pras\u012bba Lietuvai nodro\u0161in\u0101t vienu no zem\u0101kaj\u0101m cen\u0101m Eiropas Savien\u012bb\u0101 apgr\u016btina pieg\u0101des, jo tirgus ir mazs, jo \u012bpa\u0161i konkur\u0113jot ar liel\u0101kiem tirgiem, piem\u0113ram, kaimi\u0146valsti Poliju.<\/p>\n \u201cM\u0113s apzin\u0101mies probl\u0113mas un akt\u012bvi str\u0101d\u0101jam pie to risin\u0101\u0161anas. Ra\u017eot\u0101jiem nav izdev\u012bgi pieg\u0101d\u0101t mazus apjomus par zem\u0101m cen\u0101m, un ir gr\u016bti nodro\u0161in\u0101t stabilu pieg\u0101di. Tom\u0113r m\u0113s pa\u013caujamies uz savu komandu un mekl\u0113jam veidus, k\u0101 papla\u0161in\u0101t pied\u0101v\u0101jumu, b\u016bt elast\u012bgiem un optimiz\u0113t uz\u0146\u0113muma resursus. M\u0113s esam ap\u0146\u0113mu\u0161ies p\u0113c iesp\u0113jas \u0101tr\u0101k rea\u0123\u0113t un piel\u0101goties.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":" Atjaunin\u0101tais kompens\u0113jamo z\u0101\u013cu cenr\u0101dis Lietuv\u0101 st\u0101j\u0101s sp\u0113k\u0101 j\u016blij\u0101, un tas izpeln\u012bj\u0101s neviennoz\u012bm\u012bgu rezonansi. Vesel\u012bbas ministrijas skat\u012bjums K\u0101 nor\u0101da Lietuvas Vesel\u012bbas ministrija, jaunais kompens\u0113jamo z\u0101\u013cu izv\u0113les meh\u0101nisms tika ieviests pag\u0101ju\u0161aj\u0101 gad\u0101, lai racionaliz\u0113tu oblig\u0101t\u0101s vesel\u012bbas apdro\u0161in\u0101\u0161anas fonda l\u012bdzek\u013cu izmanto\u0161anu un papla\u0161in\u0101tu kompens\u0113jamo z\u0101\u013cu pieejam\u012bbu un pacientu skaitu, kas tos sa\u0146em. \u0160is meh\u0101nisms nosaka maksim\u0101lus \u201cgriestus\u201d pacientu […]<\/p>\n","protected":false},"author":220,"featured_media":6703,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_links_to":"","_links_to_target":""},"categories":[141],"tags":[],"_links":{"self":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/8533"}],"collection":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/users\/220"}],"replies":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/comments?post=8533"}],"version-history":[{"count":0,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/posts\/8533\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media\/6703"}],"wp:attachment":[{"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/media?parent=8533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/categories?post=8533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.norameda.com\/lv\/wp-json\/wp\/v2\/tags?post=8533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}